Stanford University

Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time? (2021) Ho K, Fleseriu M, Kaiser U, Salvatori R, Brue T, Lopes MB, Kunz P, et al. Journal article Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease (2021) Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH, Knoll GA, et al. Journal article Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7 (2021) Wisnovsky S, Möckl L, Malaker SA, Pedram K, Hess GT, Riley NM, Gray MA, et al. Journal article Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease (2021) McMurray JJ, Wheeler DC, Stefánsson BV, Jongs N, Postmus D, Correa-Rotter R, Chertow GM, et al. Journal article Detection of aberrant gene expression events in RNA sequencing data (2021) Yepez VA, Mertes C, Mueller MF, Klaproth-Andrade D, Wachutka L, Fresard L, Gusic M, et al. Journal article Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor plus (HR plus ) metastatic breast cancer (MBC) who have previously received a taxane (2021) O'Shaughnessy J, Schwartzberg L, Piccart M, Rugo HS, Yardley DA, Cortes J, Untch M, et al. Conference contribution Evidence of 200 TeV photons from HAWC J1825-134 (2021) Albert A, Alfaro R, Alvarez C, Camacho JRA, Arteaga-Velazquez JC, Arunbabu KP, Rojas DA, et al. Journal article First Fermi-LAT Solar Flare Catalog (2021) Ajello M, Baldini L, Bastieri D, Bellazzini R, Berretta A, Bissaldi E, Blandford RD, et al. Journal article Community-based approaches to reducing health inequities and fostering environmental justice through global youth-engaged citizen science (2021) King AC, Odunitan-Wayas FA, Chaudhury M, Rubio MA, Baiocchi M, Kolbe-Alexander T, Montes F, et al. Journal article Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial (2021) Rugo HS, Im SA, Cardoso F, Cortes J, Curigliano G, Musolino A, Pegram MD, et al. Journal article